FDA Approved Medical Products for:

Multiple myeloma

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Melphalan
Trade Name
(Manufacturer Name)
Alkeran® (injection)
(Glaxo Wellcome Inc.)
Indication
The FDA has approved this product to be used in this manner.
For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Doxorubicin HCL liposome injection
Trade Name
(Manufacturer Name)
Doxil® (injection)
(Centocor Ortho Biotech Inc.)
Indication
The FDA has approved this product to be used in this manner.
For use in combination with bortezomib for the treatment of patients with multiple myeloma who have not previously received bortezomib and have at least one prior therapy.
More Information about this product Drug Information Portal

Generic Name Carfilzomib
Trade Name
(Manufacturer Name)
Kyprolis
(Onyx Therapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.
More Information about this product Drug Information Portal

Generic Name Pomalidomide
Trade Name
(Manufacturer Name)
Pomalyst
(Celgene Corporation)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Lenalidomide
Trade Name
(Manufacturer Name)
Revlimid®
(Celgene Corporation)
Indication
The FDA has approved this product to be used in this manner.
For use in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy.
More Information about this product Drug Information Portal

Generic Name Thalidomide
Trade Name
(Manufacturer Name)
Thalomid®
(Celgene Corporation)
Indication
The FDA has approved this product to be used in this manner.
Acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Bortezomib
Trade Name
(Manufacturer Name)
Velcade®
(Millennium Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of multiple myeloma patients who have received at least one prior therapy. Treatment of patients with mantle cell lymphoma.
More Information about this product Drug Information Portal
Medline Plus Health Information